The Manufacturers Life Insurance Company Acquires New Position in Teleflex Incorporated $TFX

The Manufacturers Life Insurance Company acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 216,740 shares of the medical technology company’s stock, valued at approximately $27,474,000. The Manufacturers Life Insurance Company owned approximately 0.51% of Teleflex as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Kelleher Financial Advisors bought a new position in shares of Teleflex in the 2nd quarter worth about $25,000. Banque Cantonale Vaudoise grew its position in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the last quarter. UMB Bank n.a. raised its stake in Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 113 shares during the period. Allworth Financial LP acquired a new stake in Teleflex during the second quarter worth about $44,000. Finally, Kestra Advisory Services LLC bought a new position in Teleflex in the fourth quarter worth about $45,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

Shares of TFX opened at $137.65 on Friday. Teleflex Incorporated has a one year low of $100.18 and a one year high of $145.00. The stock’s fifty day moving average is $133.60 and its 200-day moving average is $125.81. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The firm has a market capitalization of $5.83 billion, a price-to-earnings ratio of -5.91, a price-to-earnings-growth ratio of 0.92 and a beta of 0.81.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. Teleflex’s revenue was up 28.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities analysts anticipate that Teleflex Incorporated will post 7.26 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is presently -5.84%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Piper Sandler reaffirmed an “overweight” rating and set a $169.00 target price (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. Mizuho boosted their price objective on Teleflex from $140.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, July 15th. BMO Capital Markets assumed coverage on Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective for the company. Raymond James Financial reiterated an “outperform” rating and issued a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Finally, Needham & Company LLC boosted their price target on shares of Teleflex from $159.00 to $170.00 and gave the company a “buy” rating in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $152.90.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.